Navigation Links
Orthopaedic Synergy, Inc. Announces Letter of Intent to Acquire Praxim, SA.
Date:3/9/2010

EAST TAUNTON, Mass., March 9 /PRNewswire/ -- Orthopaedic Synergy, Inc., is pleased to announce that it has entered into a letter of intent and period of exclusivity to acquire Praxim, SA of France.   

 "The acquisition of Praxim SA will represent a continuation of the philosophy of the Orthopaedic Synergy group that good companies can be brought together and managed so that the combination of their individual strengths produce shorter product development cycles and more rapid growth in sales than each company could deliver on its own," Nik Nikolaev, Chairman of Orthopaedic Synergy.   George Cipolletti, CEO and President of OMNIlife science states, "Combining OMNI's advanced orthopaedic implant and instrument products with Enztec, Ltd's instrument design capability, has already increased our ability to satisfy our customers' needs and increase our sales.  Adding Praxim's proprietary computer and robotic assisted surgery technology to the mix will serve to further accelerate this process both in the U.S. as well as in international markets."

"We believe that the OMNIlife science, Inc. product portfolio represents state of the art technology in Knee and Hip replacement and we are confident that our staff and technology and will be in good hands.  We look forward to watching OMNI, Enztec and Praxim work under the Orthopaedic Synergy banner to enhance our technology offerings as well as dramatically increase the profile and acceptance of our highly advanced proprietary computer and robotic assisted surgical techniques in orthopaedic joint replacement surgery," Christian Joly, CEO of Praxim, SA.  

About Orthopaedic Synergy, Inc.

Orthopaedic Synergy, Inc. functions as a holding company for OMNIlife Science, Inc. and Enztec, Ltd.  Together these companies represent a global reconstructive orthopaedic concern that is committed to the design, manufacture and distribution of high quality orthopaedic devices.  Our corporate strategic objectives include continued growth through strategic acquisition of companies with complementary technology to enhance the development of line extensions to our company's current product offerings as well as the introduction of new products that will allow us to provide new and improved clinical options for our customers.

About Praxim, SA

Praxim develops and commercializes advanced automated systems, software and instruments used by surgeons in the operating room to make total joint arthroplasty less-invasive, faster, more reliable and cost-effective for both patients and surgeons.  The Company's technology platforms such as the I-block surgical robot, Nano-station Computerized Surgical navigation system, and Nano-block manual surgical instruments for computer assisted surgery address key issues associated with conventional joint replacement surgical procedures – including incorrect sizing and positioning of joint replacement components that can lead to misalignments of bones ultimately leading to joint replacement failure. These can be avoided by providing highly innovative imaging protocols and advanced smart instrumentation in the operating room.

Further Information

www.Orthopaedicsynergy.com  

www.Praxim.com

www.OMNIls.com

www.Enztec.com

SOURCE Orthopaedic Synergy, Inc.

Back to top

RELATED LINKS
http://www.Orthopaedicsynergy.com

'/>"/>

SOURCE Orthopaedic Synergy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stryker Launches New Technologies and Celebrates a Major Clinical Milestone at The American Academy of Orthopaedic Surgeons Conference
2. Key Caldolor(R) Orthopedic Data to Be Presented at American Academy of Orthopaedic Surgeons Annual Meeting
3. Amedica(R) Signs Joint Venture Agreement With Orthopaedic Synergy(R)
4. Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments
5. Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries
6. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
7. Orthopaedic Surgeon Shortage Predicted Due to Soaring Joint Replacement Procedures
8. Orthopaedic Injury: High Risk to Pregnant Women
9. Children and Orthopaedic Surgical Emergencies
10. American Academy Of Orthopaedic Surgeons 2009 Annual Meeting Highlights and Hot Topics
11. MiMedx Group Announces Addition of Sales Director for Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):